(Başkent Üniversitesi, Zübeyde Hanım Uygulama ve Araştırma Merkezi, Anesteziyoloji Anabilim Dalı, İzmir, Türkiye)
Coşkun ARAZ
(Başkent Üniversitesi, Tıp Fakültesi, Anesteziyoloji Anabilim Dalı, Ankara, Türkiye)
(Başkent Üniversitesi Zübeyde Hanım Uygulama ve Araştırma Merkezi, Gastroenteroloji Anabilim Dalı, İzmir, Türkiye)
Yıl: 2018Cilt: 29Sayı: 3ISSN: 1300-4948 / 2148-5607Sayfa Aralığı: 335 - 341İngilizce

70 2
Ambulatory colonoscopy under sedoanalgesia in adult patients with and without irritable bowel syndrome: A prospective, cross-sectional, and double-blind comparison
Background/Aims: It is unclear whether patients with irritable bowel syndrome (IBS) require a high dose of sedatives during colonosco-py. In this study, we investigated the pre-procedural anxiety levels, sedative consumption, procedure times, complications, and patient’s satisfaction between patients with IBS and controls for ambulatory colonoscopy under sedation. Materials and Methods: Rome III criteria were used in the diagnosis of IBS. Anxiety levels were measured using Spielberger’s State-Trait Anxiety Inventory (STAI) and Beck Anxiety Inventory (BAI). Patients received a fixed dose of midazolam (0.02 mg/kg), fentanyl (1 μg/kg), ketamine (0.3 mg/kg), and incremental doses of propofol under sedation protocol. Demographic data, heart rate, blood pressure, and oxygen saturation were measured. Procedure times, recovery and discharge times, drug doses used, complications associated with the sedation, and patient’s satisfaction scores were also recorded. Results: The mean Trait (p=0.015), State (p=0.029), Beck anxiety scores (p=0.018), the incidence of disruptive movements (p=0.044), and the amount of propofol (p=0. 024) used were significantly higher in patients with IBS. There was a decline in mean systolic blood pressure at the 6th minute in patients with IBS (p=0.026). No association was found between the sedative requirement and the anxiety scores. Conclusion: Patients with IBS who underwent elective colonoscopy procedures expressed higher pre-procedural anxiety scores, required more propofol consumption, and experienced more disruptive movements compared with controls. On the contrary, the increased propofol consumption was not associated with the increased pre-procedural anxiety scores.
Fen > Tıp > Gastroenteroloji ve Hepatoloji
DergiAraştırma MakalesiErişime Açık
  • 26. Lee YC, Wang HP, Chiu HM, et al. Factors determining post-colo-noscopy abdominal pain: prospective study of screening colonos-copy in 1000 subjects. J Gastroenterol Hepatol 2006; 21: 1575-80. [CrossRef]
  • 25. Keszthelyi D, Troost FJ, Jonkers DM, et al. Visceral hypersensitivi-ty in irritable bowel syndrome: evidence for involvement of serotonin metabolism - a preliminary study. Neurogastroenterol Motil 2015; 27: 1127-37. [CrossRef]
  • 24. Zhou Q, Verne GN. New insights into visceral hypersensitivity – clinical implications in IBS. Nat Rev Gastroenterol Hepatol 2011; 8: 349-55. [CrossRef]
  • 23. Kanazawa M, Hongo M, Fukudo S. Visceral hypersensitivity in ir-ritable bowel syndrome. J Gastroenterol Hepatol 2011; 26: 119-21. [CrossRef]
  • 22. Chung KC, Juang SE, Lee KC, et al. The effect of pre-procedure anxiety on sedative requirements for sedation during colonoscopy. Anaesthesia 2013; 68: 253-9. [CrossRef]
  • 21. Hong JY, Jee YS, Luthardt FW. Comparison of conscious sedation for oocyte retrieval between low-anxiety and high-anxiety patients. J Clin Anesth 2005; 17: 549-53. [CrossRef]
  • 20. Osborn TM, Sandler NA. The Effects of Preoperative Anxiety on Intravenous Sedation. Anesth Prog 2004; 51: 46-51.
  • 19. Kil HK, Kim WO, Chung WY, et al. Preoperative anxiety and pain sensitivity are independent predictors of propofol and sevo-flurane requirements in general anaesthesia. Br J Anaesth 2012; 108: 119-25. [CrossRef]
  • 18. Maranets I, Kain ZN. Preoperative Anxiety and Intraoperative An-esthetic Requirements. Anesth Analg 1999; 89: 1346-51. [CrossRef]
  • 17. Tuncali B, Ozvardar Pekcan Y, Celebi A, et al. Addition of low dose ketamine to midazolam-fentanyl-propofol based sedation for colo-noscopy. J Clin Anesth 2015; 27; 301-6. [CrossRef]
  • 16. Chung F, Chan V, Ong D. A post-anesthetic discharge scoring system for home readiness after ambulatory surgery. J Clin Monit 1995; 7: 89-91. [CrossRef]
  • 15. Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with alphaxalone-alphadolone. BMJ 1974; 2: 656-9. [CrossRef]
  • 14. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893-7. [CrossRef]
  • 13. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press, 1983.
  • 12. Rome Foundation. Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. J Gastrointestin Liver Dis 2006; 15: 307-12.
  • 11. Lule E, Iddings E, Manandhar L, et al. Utility of Analgesic and Anx-iolytic Medication Dose during Colonoscopy in Identifying Patients with Irritable Bowel Syndrome. ISRN Gastroenterol 2012; 2012: 969015. [CrossRef]
  • 10. Kim ES, Cheon JH, Park JJ, et al. Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol 2010; 25: 1232-8 [CrossRef]
  • 9. Denters MJ, Schreuder M, Depla AC, et al. Patients’ perception of colonoscopy: patients with inflammatory bowel disease and irritable bowel syndrome experience the largest burden. Eur J Gastroenterol Hepatol 2013; 25: 964-72. [CrossRef]
  • 8. Fond G, Loundou A, Hamdani N, et al. Anxiety and depression co-morbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014; 264: 651-60. [CrossRef]
  • 7. Han B. Correlation between gastrointestinal hormones and anx-iety-depressive states in irritable bowel syndrome. Exp Ther Med 2013; 6: 715-20. [CrossRef]
  • 6. Deechakawan W, Heitkemper MM, Cain KC, et al. Anxiety, depression, and catecholamine levels after self-management intervention in irri-table bowel syndrome. Gastroenterol Nurs 2014; 37: 24-32. [CrossRef]
  • 5. Fukudo S, Kaneko H, Akiho H, et al. Evidence-based clinical prac-tice guidelines for irritable bowel syndrome. J Gastroeneterol 2015; 50: 11-30. [CrossRef]
  • 4. Hausteiner-Wiehle C, Henningsen P. Irritable bowel syndrome: Re-lations with functional, mental and somatoform disorders. World J Gastroenterol 2014; 20: 6024-30. [CrossRef]
  • 3. Mykletun A, Jacka F, Williams L, et al. Prevalence of mood and anx-iety disorder in self-reported irritable bowel syndrome (IBS). An epi-demiological population based study of women. BMC Gastroenterol 2010; 10: 88. [CrossRef]
  • 2. Endo Y, Shoji T, Fukudo S. Epidemiology of irritable bowel syn-drome. Ann Gastroenterol 2015; 28: 158-9.
  • 1. Singh P, Agnihotri A, Pathak MK, et al. Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. J Neurogastroenterol Motil 2012; 18: 324-31. [CrossRef]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.